A detailed history of Adirondack Trust CO transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 460 shares of TMDX stock, worth $37,227. This represents 0.03% of its overall portfolio holdings.

Number of Shares
460
Previous 460 -0.0%
Holding current value
$37,227
Previous $69,000 4.35%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 05, 2022

BUY
$12.58 - $26.94 $3,019 - $6,465
240 Added 109.09%
460 $12,000
Q4 2021

Jan 13, 2022

BUY
$19.16 - $32.68 $4,215 - $7,189
220 New
220 $4,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Adirondack Trust CO Portfolio

Follow Adirondack Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.